Latest Articles & Resources FEATURED I Peace Partners with Vita Therapeutics to Develop Universal iPSC Lines Read More » I Peace Partners with Vita Therapeutics to Develop Universal iPSC Lines Read More » LATEST NEWS + INTERVIEWS Flamma Launches New CDMO Manufacturing Facility in Dalian Hongene Biotech’s Integrated CDMO Services Advance GalNAc-Conjugated siRNA to Clinical Stage Myrtelle Partners with Charles River and Viralgen to Launch MYR-101 Production GC Cell Signs CDMO Deal with Dewcell for Stem Cell-Derived Artificial Platelets Aenova Launches Hot Melt Extrusion Platform for OEB 5 APIs at Regensburg Site Merck to Acquire Verona Pharma in $10 Billion Deal Alvotech Acquires Ivers-Lee to Expand Global Biosimilar Packaging Operations Ofichem Group Acquires Avivia to Expand Formulation Development Capabilities Amarna Therapeutics Strengthens Manufacturing Collaboration with NorthX Biologics Theratechnologies to Be Acquired by Future Pak Almac Completes Cold Chain Expansion at Craigavon HQ Circio Expands Stockholm Lab to Advance Circular RNA Drug Development Biosynth Opens Expanded GMP Bioconjugation Facility in Berlin European Small Molecule Manufacturing at Critical Juncture as Green Rules Meet Market Reality BioSpring Breaks Ground on One of World’s Largest Nucleic Acid API Sites in Germany WuXi XDC Achieves Mechanical Completion of 25,000 m² Singapore Bioconjugate Site Merck KGaA Completes Acquisition of SpringWorks Therapeutics Axplora Invests €35M to Expand Farmabios Site in Italy Kaneka Eurogentec’s New GMP mRNA Facility Now Ready for Vaccine and Gene Therapy Production Hikma Pharmaceuticals to Invest $1B in US Manufacturing by 2030 Aenova to Launch 6,500m³ Cold Chain Facility at Latina Site by 2026 PODCAST INTERVIEWS European Small Molecule Manufacturing at Critical Juncture as Green Rules Meet Market Reality 10 Things I’d Do Differently When Fast Tracking Emergency Drug Manufacturing How To Build Biotechs from First Principles: Deep Science Ventures’ Formula for Science-based Innovation
How To Build Biotechs from First Principles: Deep Science Ventures’ Formula for Science-based Innovation